AbbVie is once again the top spender on pharma TV ads, narrowly beating April's winner, Rexulti. That’s according to the latest data from real-time TV ad trackers at iSpot.TV, who crunched May’s ...
AbbVie’s Skyrizi took home the top spot for most pharma brand ad impressions in April, according to data released by iSpot.tv on Wednesday afternoon. The psoriasis treatment garnered an impressions ...
In the back and forth rivalry atop the list of Rx and over-the-counter (OTC) brands, Skyrizi has once again overthrown Dupixent as the leader of the pack. The Crohn’s disease, psoriasis and psoriatic ...
Physicians have delivered a boost to AbbVie’s hopes of turning Skyrizi into a $17-billion-a-year drug. The 101 gastroenterologists polled by Spherix Global Insights talked up Skyrizi’s promise in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback